
ResVita Bio
2025年1月2日 · ResVita Bio is a therapeutics company dedicated to developing life-changing treatments for skin diseases. Our proprietary platform leverages engineered bacteria to deliver therapeutic proteins directly to affected areas, providing a …
Startup ResVita Bio Targets Rare, Deadly Skin Disease With a …
ResVita has a rare pediatric disease designation from the FDA, though that program sunset Dec. 20, a victim of Congress’ budget-continuance bill. It also plans to apply for “orphan” and “breakthrough therapy” designations, which give financial benefits and speed the FDA review process for drugs to treat rare or serious conditions.
Ethical Innovation: ResVita Bio Uses L'Oréal's Leading Skin …
A synthetic biology startup at Bakar Labs, ResVita Bio, has developed a cutting-edge therapeutic that is both user-friendly and revolutionary: a living therapeutic applied once a day, working like the body’s own cells to repair deficiencies. Their therapeutic is applied as a moisturizer, but it contains specially engineered bacterial cells.
ResVita Bio Announces Successful FDA INTERACT Meeting for …
2024年10月23日 · This milestone underscores the alignment between the FDA and ResVita Bio's new platform for continuous protein therapy—a groundbreaking therapeutic approach designed to deliver sustained drug ...
NIH Awards ResVita Bio a $2M Phase II SBIR Grant for Continuous …
ResVita Bio, a synthetic biology company, announced that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the NIH has awarded the company a $2.03M Phase II Small Business Innovation Research (SBIR) grant to advance RVB-003, a novel treatment for Netherton Syndrome, a chronic and life-threatening genetic skin ...
ResVita Bio receives Rare Pediatric Disease Designation for RVB …
BERKELEY, Calif., June 9, 2022 /PRNewswire/ -- ResVita Bio, a cellular therapies startup, announces that the FDA has granted Rare Pediatric Disease Designation to RVB-001 to treat Netherton...
Resvita Biosciences | Intellectual Property & Industry Research …
Resvita Biosciences has a unique patented approach, a rich product pipeline, clear regulatory advantages, and an experienced scientific management team. The company is developing multiple anti-aging products, an investigational drug to treat an orphan skin disease, and treatments for inflammatory skin diseases like eczema and psoriasis.
ResVita Bio - LinkedIn
ResVita Bio seeks to restore and maintain the vitality of the skin through engineered skin probiotics. Through synthetic biology and metabolic engineering, we are developing a safe and...
Resvita Capsule: Buy strip of 10.0 capsules at best price in India
Resvita Capsule is a nutritional supplement enriched with resveratrol, grape seed extract, eicosapentaenoic acid, docosahexaenoic acid, selenium, zinc and chromium. Regular consumption supports a healthy heart, boosts high-density lipoprotein, manages deficiency of omega-3 fatty acids, and reduces fatty plaques inside the artery and blood clotting.
- 评论数: 82
Resvita Bio 2025 Company Profile: Valuation, Funding & Investors ...
Developer of a synthetic biology platform intended to create innovative treatments for skin diseases.